SCHEMBL12002995

SCHEMBL12002995

COc1cc(Cl)nnc1N1CCC(N)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SUV39H2 Q9H5I1 11/20 0.41
HTR3E A5X5Y0 1/20 0.40
MEN1 O00255 1/20 0.40
HTR3B O95264 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
NFKB1 P19838 1/20 0.40
HTR3A P46098 1/20 0.40
KMT2A Q03164 1/20 0.40
HTR3D Q70Z44 1/20 0.40
HTR3C Q8WXA8 1/20 0.40
PDE5A O76074 2/20 0.36
ENPP1 P22413 1/20 0.36
ADRA1D P25100 2/20 0.36
ADRA1B P35368 2/20 0.36
SSTR2 P30874 1/20 0.36
ADRA1A P35348 1/20 0.36
GAK O14976 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22042474 0.83 SMN1; SMN2 (0.46) MEN1CYP1A2KMT2APDE5AENPP1
SCHEMBL31092659 0.83 SMN1; SMN2 (0.46) MEN1CYP1A2KMT2APDE5AENPP1
SCHEMBL31000090 0.79 SMN1; SMN2 (0.53) CYP1A2CYP2D6TSHRKMT2APDE5A
SCHEMBL31000161 0.77 PDE5A (0.42) PDE5AGAKALDH1A1SMN1; SMN2
SCHEMBL31000267 0.73 ENPP1 (0.36) ENPP1ALDH1A1SMN1; SMN2
SCHEMBL20582119 0.68 MALT1 (0.34) MEN1KMT2AALDH1A1
SCHEMBL7276406 0.68 ENPP1 (0.73) ENPP1
SCHEMBL4490992 0.68 HTR3E (0.43) SUV39H2HTR3EMEN1HTR3BCYP1A2
SCHEMBL25528793 0.67 ALDH1A1 (0.41) CYP1A2ALOX15ALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL22441562 0.67 ENPP1 (0.72) ENPP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2148873-B1 4-ALKOXYPYRIDAZINE DERIVATIVES AS FAST DISSOCIATING DOPAMINE 2 RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2012-08-29 EP disclosed